EUS-guided Procore-biopsy in Diagnosing Autoimmune Pancreatitis

Technical University of Munich16 enrolled

Overview

The goal of this prospective study is to evaluate the feasibility of the Core Biopsy Needle with reverse bevel (Procore TM) in diagnosing autoimmune pancretitis

Study Type

INTERVENTIONAL

Allocation

Purpose

DIAGNOSTIC

Masking

NONE

Enrollment

Conditions

Autoimmune Pancreatitis

Interventions

Procore-NeedleDEVICE

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * patient age 18 years and older * patients with suspicion of autoimmune pancreatitis (based on the findings in EUS and MRI) Exclusion Criteria: * unable to obtain informed consent * ASA class 4 and 5 * known pregnancy * contraindication for endoscopy or for biopsy sampling * patients with high suspicion on pancreatic cancer (based on the findings in radiology and EUS)

Locations (1)

Klinikum rechts der Isar

Munich, Bavaria, Germany

RECRUITING

Outcomes

Primary Outcomes

diagnostic yield

Number of patients with adequate tissue sample (which allows definitive diagnosis)

Time frame: 6 months

Central Contacts

Stefan von Delius, MD

CONTACT

stefan_ruckert@yahoo.de

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.